Spirometry and dyspnea in patients with COPD - When small differences mean little

被引:78
作者
Redelmeier, DA
Goldstein, RS
Min, ST
Hyland, RH
机构
[1] UNIV TORONTO,DEPT MED,TORONTO,ON,CANADA
[2] W PK HOSP,DIV RESPIROL,TORONTO,ON,CANADA
[3] UNIV TORONTO,WELLESLEY HOSP,DIV RESPIROL,TORONTO,ON M4Y 1J3,CANADA
关键词
COPD; dyspnea; spirometry;
D O I
10.1378/chest.109.5.1163
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine when a difference in FEV(1) is sufficiently large to be associated with a noticeable difference in dyspnea symptoms for patients with chronic lung disease. Design: Cross-sectional analysis of 15 groups (n=112 patients, 832 contrasts). Setting: Respiratory rehabilitation program. Patients: Patients with COPD (mean FEV(1)=35% predicted). Measures: Patients' perspectives assessed through subjective comparison ratings of dyspnea and of overall health. Relation between the FEV(1) and patients' perspectives determined the smallest difference in spirometry that was associated with a noticeable difference in patients' symptoms. Results: The FEV(1) was moderately correlated with patients' ratings of dyspnea (r=0.29; 95% confidence interval (CI), 0.22 to 0.35). In contrast, the FEV(1) was minimally con,elated with patients' ratings of overall health (r=0.10; 95% CI, 0.03 to 0.17). The FEV(1) needed to differ by 4% predicted for the average patient to stop rating his or her dyspnea as ''about the same'' and start rating his or her dyspnea as either ''a little bit better'' or ''a little bit worse'' relative to other patients (95% CI, 1.5 to 6.5), This was equivalent to the average patient's FEV(1) increasing by 112 mL (starting from 975 mL and ending at 1,087 mL). Conclusions: Some statistically significant differences in the FEV(1) are so small that they may not represent important differences in symptoms for the average patient with severe COPD; an awareness of the smallest difference in FEV(1) that is noticeable to patients can help clinicians interpret the effectiveness of symptomatic treatments.
引用
收藏
页码:1163 / 1168
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[2]   THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION [J].
BURROWS, B ;
BLOOM, JW ;
TRAVER, GA ;
CLINE, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) :1309-1314
[3]  
Cohen J., 1969, STAT POWER ANAL BEHA
[4]   CURRENT CONCEPTS - PULMONARY-FUNCTION TESTING [J].
CRAPO, RO .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (01) :25-30
[5]  
D'Amato M. R., 1970, EXPT PSYCHOL METHODO
[6]   EFFICACY OF THEOPHYLLINE IN IRREVERSIBLE AIR-FLOW OBSTRUCTION [J].
EATON, ML ;
GREEN, BA ;
CHURCH, TR ;
MCGOWAN, T ;
NIEWOEHNER, DE .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) :758-761
[7]   NATURAL-HISTORY OF CHRONIC AIR-FLOW OBSTRUCTION [J].
FLETCHER, C ;
PETO, R .
BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6077) :1645-1648
[8]   RANDOMIZED CONTROLLED TRIAL OF RESPIRATORY REHABILITATION [J].
GOLDSTEIN, RS ;
GORT, EH ;
STUBBING, D ;
AVENDANO, MA ;
GUYATT, GH .
LANCET, 1994, 344 (8934) :1394-1397
[9]  
GUYATT GH, 1987, CAN MED ASSOC J, V137, P1089
[10]  
Hulley SB, 1988, DESIGNING CLIN RES